BriaCell Therapeutics Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$4,791,466 over the previous period. Total operating expenses were $33,330,076.
Profit Margin
| 2015 | 0 | -2.68M | |
|---|---|---|---|
| 2016 | 0 | -1.69M | |
| 2017 | 0 | 0 | |
| 2018 | 0 | 1.06M | |
| 2019 | 0 | 946.42K | |
| 2020 | 0 | 1.38M | |
| 2021 | 0 | 3.68M | |
| 2022 | 0 | -11.54M | |
| 2023 | 0 | -20.30M | |
| 2024 | 0 | -4.79M |
BCTXW Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 27.17M | 15.33M | 8.02M | 1.31M | 2.22M | 3.73M | 2.38M | 0 | 723.42K | 105.82K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 33.33M | 23.27M | -3.38K | -3.68M | -1.38M | -946.42K | -1.06M | 0 | 1.66M | 1.44M |
Operating income | -4.79M | -23.27M | -15.28M | -6.97M | -3.60M | -4.73M | -3.81M | 0 | -1.66M | -1.44M |
Other income (expenses), net | 0 | 2.96M | -30.73K | 6.58M | -85.09K | 343.74K | -331.39K | 0 | -32.40K | -1.24M |
Income before tax | -4.79M | -20.30M | -11.54M | 3.68M | 1.38M | 946.42K | 1.06M | 0 | -1.69M | -2.68M |
Income tax expense | 0 | -152.62K | 979 | 6.58M | -72.25K | 343.74K | -331.39K | 0 | 29.23K | 1.24M |
Net income | -4.79M | -20.30M | -11.54M | 3.68M | 1.38M | 946.42K | 1.06M | 0 | -1.69M | -2.68M |
Earnings per share | ||||||||||
Basic EPS | -0.29 | -1.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Diluted EPS | -0.29 | -1.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Data source | Data source | Data source |